MLLT3 and acute myeloid leukemia: To characterize the impact of exogenous TPO on HSC-derived iKMT2A-MLLT3-driven AML, we compared the gene expression signatures from emerging leukemic cells (“bulk”) (Supplementary Fig. 4A).